Revolution Medicines, Inc. is 9.4x more valuable than Denali Therapeutics Inc. by market capitalization ($30.74 B vs $3.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DNLI | RVMD |
|---|---|---|
| Market cap | $3.27 B | $30.74 B |
| US-listed rank | #1734 | #453 |
| Revenue (latest FY) | $0.00 | $0.00 |
| Net income (latest FY) | -$512.54M | -$1.13B |
| SEC filings | 763 | 782 |
Revolution Medicines, Inc. is 9.4x more valuable than Denali Therapeutics Inc. by market capitalization ($30.74 B vs $3.27 B).
In their latest fiscal years, Denali Therapeutics Inc. reported $0.00 in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Denali Therapeutics Inc. and Revolution Medicines, Inc., or browse the full rankings.